The issues of individualized medicine and pharmacovigilance: A consideration of COVID-19 and vaccination.

The article discusses how vaccination against COVID-19, is a current challenge with mass exposure to new agents which will be used in some disposition that may either mean the vaccines may not be as effective as found in relatively small numbers in the studies, or those with vulnerability or disease that makes individuals prone to adverse effect. It also highlights need of health professionals, scientists and politicians must play their part in evaluations and interpretation.